Provided by Tiger Trade Technology Pte. Ltd.

AbbVie

264.96
+3.131.20%
Post-market: 266.401.44+0.54%19:59 EDT
Volume:5.16M
Turnover:1.37B
Market Cap:468.29B
PE:74.85
High:266.84
Open:260.70
Low:260.10
Close:261.83
52wk High:267.47
52wk Low:190.75
Shares:1.77B
Float Shares:1.76B
Volume Ratio:1.05
T/O Rate:0.29%
Dividend:6.83
Dividend Rate:2.58%
EPS(TTM):3.54
EPS(LYR):2.36
ROE:6225.00%
ROA:10.51%
PB:-78.90
PE(LYR):112.27

Loading ...

Abbvie Inc. Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Jul 15

Abbvie Currently Down Seven Consecutive Days, on Pace for Longest Losing Streak Since March 2025

Dow Jones
·
Jul 14

Skinmedica® Deepens Commitment to Regenerative Science with Continued Investment in Research and Development

THOMSON REUTERS
·
Jul 14

Therapeuticsmd Inc. Stock Underperforms Monday When Compared to Competitors

Dow Jones
·
Jul 14

Abbvie is Maintained at Neutral by UBS

Dow Jones
·
Jul 14

AbbVie price target raised to $260 from $230 at UBS

TIPRANKS
·
Jul 14

UBS Adjusts Price Target on AbbVie to $260 From $230, Maintains Neutral Rating

MT Newswires Live
·
Jul 13

BMO Lifts Abbvie PT, Sees Continued Strength in Immunology Drugs

Reuters
·
Jul 13

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Jul 13

Abbvie : Bmo Raises Target Price to $300 from $258

THOMSON REUTERS
·
Jul 13

Abbvie is Maintained at Buy by B of a Securities

Dow Jones
·
Jul 11

Biopharma Pricing Power Seen as Key Swing Factor for Q2 Earnings, BofA Says

MT Newswires Live
·
Jul 11

BofA Securities Adjusts AbbVie Price Target to $276 From $234

MT Newswires Live
·
Jul 10

Abbvie : Bofa Global Research Raises Price Objective to $276 from $234

THOMSON REUTERS
·
Jul 10

AbbVie's Q2 Results Expected to be Inline With Expectations, RBC Says

MT Newswires Live
·
Jul 10

Biopharma Dealmaking on Way to Record Year, Says HSBC

Reuters
·
Jul 10

AbbVie price target raised to $295 from $260 at Wells Fargo

TIPRANKS
·
Jul 10

Wells Fargo Sticks to Their Buy Rating for AbbVie (ABBV)

TIPRANKS
·
Jul 10

Therapeuticsmd Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jul 10

Abbvie Inc. Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Jul 10